Parkinson's disease (PD) is a neurodegenerative brain disorder characterized by selective dopaminergic (DAergic) cell loss that results in overt motor and cognitive deficits. Current treatment options exist to combat PD symptomatology, but are unable to directly target its pathogenesis due to a lack of knowledge concerning its etiology. Several genes have been linked to PD, including three genes associated with an early-onset familial form: parkin, pink1 and dj1. All three genes are implicated in regulating oxidative stress pathways. Another hallmark of PD pathophysiology is Lewy body deposition, associated with the gain-of-function genetic risk factor a-synuclein. The function of a-synuclein is poorly understood, as it shows both neurotoxic and neuroprotective activities in PD. Using the genetically tractable invertebrate Caenorhabditis elegans (C. elegans) model system, the neurotoxic or neuroprotective role of a-synuclein upon acute Mn exposure in the background of mutated pdr1, pink1 or djr1.1 was examined. The pdr1 and djr1.1 mutants showed enhanced Mn accumulation and oxidative stress that was reduced by a-synuclein. Moreover, DAergic neurodegeneration, while unchanged with Mn exposure, returned to wild-type (WT) levels for pdr1, but not djr1.1 mutants expressing a-synuclein.
Introduction
Parkinson's disease (PD) is the second most common neurodegenerative disorder in the U.S., affecting nearly 1% of the population. 1 With an age of onset typically around 60 years of age, this disease manifests a selective dopaminergic (DAergic) neuronal loss in the substantia nigra pars compacta (SNpc), resulting in overt motor and cognitive deficits. 2 The cardinal motor symptomatology of PD includes bradykinesia, rigidity, tremors and postural instability that may be preceded by emotional instability and cognitive problems. 3 As age remains the most significant risk factor for PD pathogenesis, the ever-increasing human lifespan has produced a financial and emotional burden worldwide. Untenable treatment options that do not target the etiology of PD are a major public health concern, and warrant further investigations into the specific mechanisms behind PD pathophysiology. While the majority of PD cases are idiopathic, many genes have now been associated with the disease, including DJ1, PINK1, parkin, NURR1, LRRK2, UCH-L1, and a-synuclein. 3 The current study focuses on the major early-onset, familial PD genes: parkin, pink1 and dj1. Homozygous mutations in the PARK2/parkin gene are responsible for nearly 50% of an autosomal recessive, early-onset, familial form of PD. 4 This gene proteasome system (UPS) that targets substrates for degradation. 5 Mutations in this gene result in impaired ligase activity and substrate binding that can lead to increased protein aggregation. 6 Parkin knockout (KO) models show a variety of PD-associated phenotypes, including hypokinetic deficits, DAergic cell loss 7 and increased extracellular dopamine (DA) levels in the striatum. 8 The PD-associated protein known as PINK1, or PTENinduced kinase 1, is a mitochondrial-targeted protein that contains a highly conserved serine/threonine kinase domain. 9 Homozygous mutations in PARK6/pink1 are also connected to autosomal recessive, early-onset PD. 10 These mutations typically result in impaired kinase activity 11 that is otherwise critical for maintaining mitochondrial integrity, as phosphorylation targets include mitochondrial fission and fusion factors, 12 as well as the mitochondrially-located serine protease HtrA2. 13 Wildtype PINK1
has been shown to protect against mitochondrial toxin-induced DAergic cell death, as well as reducing apoptotic caspase levels and mitochondrial cytochrome c release. 14 pink1 mutants show increased DAergic cell death 15 and impaired DA release. 16 Recent studies have identified parkin as a PINK1 phosphorylation target. In fact, these two proteins work in parallel to promote mitophagy through a PINK1-mediated phosphorylation (and autophosphorylation) and recruitment of parkin to mitochondria with a lowered membrane potential. 17 Various modulators of this interaction have recently been introduced, including the mitochondrial fusion factor Mitofusin 2 (Mtfn2) and voltage-dependent anion channels (VDACs) . 18 This novel role for both parkin and PINK1 reveals the importance of maintaining proper mitochondrial trafficking and turnover, signifying an impaired clearance of defective mitochondria as a potential mechanism in the pathophysiology of PD. Additionally, mutations in the PARK7/dj1 gene are also associated with autosomal recessive, early-onset PD. 19 This gene encodes for a protein that functions as an oxidative stress sensor, where oxidation of a cysteine residue results in translocation of the acidic isoform from the cytoplasm to the mitochondria. 20 Mutations in dj1 result in increased ROS levels, impaired mitochondrial energetics 21 and DAergic cell death, while overexpression protects against DA toxicity and cell loss.
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DJ1 has also been shown to form a multi-protein complex with parkin and PINK1, 23 though this remains controversial. Moreover, DJ1 up-regulation can reduce the loss of PINK1-mediated sensitization of DAergic neurons in the SNpc to a mitochondrial toxin. 24 The reduction of pink1 loss-mediated mitochondrial deficits by DJ1 was also seen in Drosophila, but no reduction was seen in parkin mutants. 25 These data reveal the role of DJ1 acting in parallel with the parkin/PINK1 pathway. Another gene implicated in PD pathophysiology is SNCA 26 that encodes for a-synuclein (a-Syn), the major aggregated component of Lewy body depositions. Pathogenic mutations in the SNCA gene have been shown to promote increased aggregation of the protein. 27 While the function of a-Syn remains unclear, high expression is found in neuronal presynaptic terminals. Recent evidence has implicated a-Syn in regulating synaptic vesicle release, mobility and recycling, 28 along with decreased DA release from vesicles in the background of a-Syn overexpression. 29 Wildtype a-Syn has been shown to inhibit tyrosine hydroxylase (TH) activity, suggesting a physiological role in controlling optimal DA biosynthesis. 30 However, aggregated forms are no longer able to inhibit TH activity, with higher TH phosphorylation present. 31 Elucidating the role of wildtype a-Syn in the background of other PD genes may provide deeper insight into the neuroprotective or neurotoxic nature of a-Syn in PD.
While genes such as SNCA, parkin, pink1 and dj1 may be associated with PD, the heterogeneity in age-of-onset, as well as 90% of cases being sporadic in nature, warrants investigation into the role of environmental factors in PD etiology. One such factor is manganese (Mn). This is an essential trace element that is necessary for proper immune function, bone growth, digestion, reproduction, as well as for serving as an important cofactor for many enzymes. 32 However, overexposure can result in symptomatology that resembles PD. 33 Environmental sources of Mn exposure can include drinking water (groundwater), pesticides, manufacturing by-products, and airborne exposure upon combustion of the fuel additive methylcyclopentadienyl manganese tricarbonyl (MMT). However, excessive occupational Mn exposure may also arise from welding, steel mining, smelting, and other industrial occupations. 34 Several studies have already begun to examine gene-environment interactions between Mn exposure and PD-associated genes. For example, rats exposed to Mn-containing welding fumes show an increase in parkin protein levels; 35 parkin was also shown to selectively protect against Mn-induced DAergic cell death in vitro.
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In this work, the tractable, invertebrate Caenorhabditis elegans (C. elegans) model system expressing human wildtype a-Syn was used for the first time to examine the roles of several early-onset, PD-associated genes (pdr1, pink1 and djr1.1) and a-Syn in mediating Mn-induced neurotoxicity. Thereby, Mn uptake and Mn-induced oxidative stress in the background of mutated pdr1, pink1 and djr1.1 are illustrated. Furthermore, this paper demonstrates a novel role for a-Syn in altering Mn accumulation in the background of mutated genes (pdr1 and djr1.1) through the utilization of inductively coupled plasmamass spectrometry (ICP-MS/MS), as well as visualizing intraworm Mn levels using laser ablation-inductively coupled plasma-mass spectrometry (LA-ICP-MS).
Mn quantification in C. elegans
Mn content was determined after ashing of L1 worms by ICP-MS/MS. Briefly, 50 000 synchronized L1 worms were acutely treated with MnCl 2 . Worms were pelleted, washed five times in 85 mM NaCl and re-suspended in 1 mL 85 mM NaCl supplemented with 1% protease inhibitor. After sonication, an aliquot was taken for protein quantification using the bicinchoninic acid (BCA) assay-kit (Thermo Scientific). Subsequently, the suspension was mixed again, evaporated, and incubated with the ashing mixture (65% HNO 3 Additionally, the Mn content was qualitatively confirmed by LA-ICP-MS analyses. Briefly, 50 000 synchronized L1 worms acutely exposed to MnCl 2 were pelleted and washed three times with 85 mM NaCl and two times with bidistilled water. Worms were prepared for analyses by drying single worms on microscopic slides (Thermo Scientific).
The laser ablation system LSX213G2+(CETAC Technologies) was coupled to an ICP-MS (ICAP Qc, Thermo Fisher Scientific). Slides were placed in the ablation chamber and ablated linewise using a quintupled Nd:YAG laser (wavelength 213 nm, repetition frequency 20 Hz spot, spot diameter 4 mm). The ablated material was transported into the ICP-MS by the carrier gas (He/Ar) and analytes were determined using the MS in KEDS mode (Tables 2  and 3 ). In addition, a 10 mg L À1 Rh-solution including 2% HNO 3 was continuously delivered into ICP via a cyclonic spray chamber to compensate for drift effects during analysis.
Dopaminergic degeneration assay
Synchronized L1 worms (2500 per tube) were acutely exposed to MnCl 2 . Upon washing, all worms were plated on OP50-seeded NGM plates. Forty-eight hours post-treatment, 50 worms were transferred to fresh OP50-seeded NGM plates and blinded for subsequent imaging. At 72 hours post-treatment, 15 worms per condition were mounted onto 4% agar pads (in M9 buffer) and anesthetized with 0.2% tricaine/0.02% tetramisole in M9 buffer. Scoring of neuronal defects was performed using an epifluorescence microscope (Nikon Eclipse 80i) equipped with a Lambda LS Xenon lamp (Sutter Instrument Company) and Nikon Plan Fluor 20Â dry and Nikon Plan Apo 60Â 1.3 oil objectives. Each worm was scored for the absence (''normal'') or presence of any of the following morphological changes: puncta formation along dendritic processes; shrunken soma; and/or loss of soma and/or dendrites (''degenerated''). Representative confocal images (Carl Zeiss MicroImaging, Inc.) of each morphological phenotype were taken and processed as previously described. 39 
RONS measurements
The formation of reactive oxygen and nitrogen species (RONS) in whole L1 worms was evaluated by a 5(&6)-carboxy-2 0 ,7 0 -dichlorodihydrofluorescein-diacetate (carboxy-DCFH-DA)-based plate reader View Article Online system. Briefly, a carboxy-DCFH-DA stock solution (50 mM in DMSO) (Invitrogen) was diluted 1 : 100 with M9 buffer, and synchronized L1 worms were exposed to 500 mM for 1 h in the dark. After 1 h, the worms were washed two times with M9 buffer and two times with 85 mM NaCl to remove all the carboxy-DCFH-DA content outside the worms. 10 000 worms were transferred to each well of a 96-well plate and incubated with H 2 O 2 (positive control) or MnCl 2 (respective LD 25 concentration). Immediately after incubation, the intracellular oxidation of carboxy-DCFH, which correlates with intracellular RONS, was monitored (excitation 485 nm/emission 535 nm) by a microplate reader (FLUOstar Optima microplate reader, BMG Labtechnologies), and kinetics were constructed up to 420 min. To exclude interfering fluorescence of the matrix, data were normalized to a control (dye-loaded cells without a RONS generator).
Glutathione quantification
Total intracellular glutathione levels (reduced and oxidized GSH) were determined using the ''enzymatic recycling assay'', as previously described. 40 Briefly, whole worm extracts were prepared out of 50 000 L1 worms acutely exposed to MnCl 2 . This was followed by washing with 85 mM NaCl and sonication of the pellet in 0.1 mL ice cold extraction buffer (1% Triton X-100, 0.6% sulfosalicylic acid) and 1% protease inhibitor in KPE buffer (0.1 M potassium phosphate buffer, 5 mM EDTA). Intracellular GSH was quantified by measuring the change in absorbance per minute at 412 nm by a microplate reader after reduction of 5,5 0 -dithio-2-nitrobenzoic acid (DTNB, SigmaAldrich).
TaqMan gene expression assay
Total RNA was isolated via the Trizol method. Briefly, following treatment, 1 mL of Trizol (Life Technologies) was added to each tube containing worms resuspended in 100 mL 85 mM NaCl, followed by three cycles of freezing in liquid nitrogen and thawing at 37 1C. 200 mL of chloroform was then added to each tube, followed by precipitation using isopropanol and washing with 75% ethanol. Following isolation, 1 mg total RNA was used for cDNA synthesis using the High Capacity cDNA Reverse Transcription Kit (Life Technologies), as per manufacturer's instructions. cDNA samples were stored at 4 1C. Quantitative real-time PCR (BioRad) was conducted in duplicate wells using TaqMan Gene Expression Assay probes (Life Technologies) for each gene, using the afd-1 (actin homolog) housekeeping gene for normalization after determining the fold difference using the comparative 2 ÀDDCt method. 41 The following probes were used: human dat-1 (assay ID: Ce02450891_g1); skn-1 (assay ID: Ce02407447_g1); and afd-1 (assay ID: Ce02414573_m1).
Statistics
Dose-response lethality curves and all histograms were generated using GraphPad Prism (GraphPad Software Inc.). A sigmoidal dose-response model with a top constraint at 100% was used to draw the lethality curves and determine the respective LD 50 values (values represent the respective Mn concentrations that induce 50% reduction in survival), followed by a one-way analysis of variance (ANOVA) with a Dunnett's post-hoc test to compare all strains to their respective control strains. In order to compare all a-Syn to non-a-Syn-containing strains, a one-way ANOVA using Bonferroni's multiple comparison post-hoc test was conducted. Two-way ANOVAs were performed on the metal content, RONS, GSH and TaqMan gene expression data, followed by Bonferroni's multiple comparison post-hoc tests. Degeneration data were plotted as a stacked histogram and analyzed using an unpaired t-test between groups (vs. respective control strains).
Results
pdr1 mutants are hypersensitive to acute Mn exposure Assessment of dose-response survival curves following acute Mn exposure revealed a leftward-shift in the curve for pdr1 mutant worms compared to N2 wild-type (WT) worms (Fig. 1A) . Thus, pdr1 mutants exhibited hypersensitivity to Mninduced lethality (LD 50 = 5.59 mM) compared to WT worms (LD 50 = 10.43 mM). djr1.1 mutants were less sensitive to acute Mn exposure vs. WT worms. djr1.1, one of the two djrorthologues, shows the highest homology to vertebrate dj1 and broadest expression (similar to the other deletion mutants). 42 Therefore, all studies were carried out in the djr1.1 orthologue. Treating worms containing human WT a-Syn in addition to the respective genetic deletions ( pdr1, pink and djr1.1) with Mn led to increased sensitivity compared to the WT a-Syn control strain (Fig. 1B) . One-way ANOVA analysis (comparing data from Fig. 1A and B) showed a significantly increased sensitivity of the a-Syn-containing djr1.1 mutants towards Mn compared to the djr1.1 mutants alone (Fig. 1C) .
Enhanced Mn accumulation in pdr1 and djr1.1 mutants is attenuated by WT a-Syn expression
To determine whether a genetic deletion and/or the presence of WT a-Syn alters Mn bioavailability in C. elegans, the Mn content was measured by ICP-MS/MS. Overall, the analyzed strains ( Fig. 2A and B) showed a dose-dependent increase in the Mn content (two-way ANOVA, concentration p o 0.0001). The pdr1 and djr1.1 deletion mutants exhibited an enhanced Mn accumulation compared to WT worms ( Fig. 2A) . pink1 mutants showed Mn accumulation that was indistinguishable from WT worms ( Fig. 2A) . Notably, the pdr1 and djr1.1 mutants containing a-Syn accumulated less Mn compared to the respective deletion mutants alone ( Fig. 2C and D) . While the reduction effect was not significant for the pdr1 mutants (Fig. 2C) , the decrease in accumulation was significant at 7.5 and 10 mM Mn for the djr1.1 mutants (Fig. 2D) . Moreover, we qualitatively confirmed the intraworm Mn accumulation using LA-ICP-MS. WT and djr1.1 mutants, with and without a-Syn, were treated acutely with LD 50 dose (10 mM) (Fig. 1) . The images corroborate the ICP-MS/MS metal content analyses, showing increased Mn accumulation in the djr1.1 mutants compared to the a-Syn-containing djr1.1 mutants (Fig. 2E) .
Absence of Mn-induced DAergic neurodegeneration
Next, we determined whether the aforementioned Mn concentrations induce dopaminergic (DAergic) neurodegeneration. Visualization of the architecture of the four cephalic (CEP) DAergic neurons in the head was performed using worms expressing the green fluorescent protein (GFP) under the control of a promoter for the dopamine re-uptake transporter 1 (C. elegans orthologue for vertebrate DAT 43 ), p dat-1 ::GFP (vtIs1). Using an objective scoring system, the CEP neurons were scored as degenerated if they exhibited any of the following: discontinuous, punctated GFP signal in the dendrites (3A, II); shrinkage of the cell body (3A, III); and/or, ultimately, total loss of soma and/or dendritic GFP signal (Fig. 3A, IV) . Mn treatment did not significantly increase the inherent DAergic neurodegeneration in WT worms and deletion mutants (Fig. 3B, a-c) . Assessment of neurodegeneration at 24 and 48 hours post-treatment (larval stages) also showed no change in DAergic neurodegeneration (data not shown). However, the a-Syn-containing pdr1 deletion mutants show a reduction in the degeneration of the CEP architecture, while the a-Syn-containing djr1.1 deletion mutants do not.
Mn-induced oxidative stress is exacerbated in pdr1 and djr1.1 mutants, but reduced by a-Syn expression
Oxidative stress is implicated in Mn-induced neurotoxicity. 44 Additionally, parkin, pink and dj1 are all involved in regulating oxidative stress pathways. 45 Therefore, we investigated the relationship between Mn, oxidative stress and defense responses by measuring the presence of RONS and total GSH levels. To determine the presence of RONS in whole worms, a carboxy-DCFH-DA based reader test system was established (data not shown). Fig. 4A shows Mn-induced RONS levels in WT worms, pdr1 and djr1.1 mutants, along with their respective a-Syn-expressing strains. In response to sub-lethal, acute Mn treatment (respective LD 25 ), WT worms showed a time-dependent increase in Mn-induced RONS that was exacerbated in pdr1, pink1 and djr1.1 mutants (data are normalized to the respective controls (dye-loaded cells without a RONS generator) at each respective timepoint). As illustrated in Fig. 4A (c and d) , pdr1 and djr1.1 mutants containing a-Syn showed a lower Mn-induced RONS level compared to the nona-Syn expressing deletion mutants. Next, GSH levels were analysed in the deletion mutants to ascertain their redox status. The deletion mutants contained significantly less total GSH than WT worms (Fig. 4B) . Mn treatment resulted in a slight reduction in GSH levels, which did not attain statistical significance. The significant decrease in GSH levels at 10 mM Mn in the pdr1 mutants likely reflects Mn-induced lethality at this dose (Fig. 1A) . The a-Syn-containing deletion mutants showed similar effects as the deletion mutants alone (data not shown). Treatment with H 2 O 2 as a positive control corroborated that the inherently decreased levels of GSH in the mutants represent an innately defective oxidative stress response, as H 2 O 2 treatment did not significantly alter GSH levels from baseline levels as compared to WT worms (data not shown).
Increased skn-1 mRNA expression in djr1.1 and pink1 mutants To determine whether the differences in oxidative stress levels are associated with differences in cellular defense responses against oxidative stress, expression of the antioxidant response gene skn-1, the orthologue of the vertebrate gene nrf2, 46 was examined. Gene expression data reveal inherently upregulated skn-1 mRNA levels in the deletion mutants compared to WT View Article Online worms (Fig. 5A) , reaching statistical significance in the pink1 and djr1.1 mutants. Acute Mn treatment resulted in an upregulation of skn-1 mRNA at the LD 50 dose only in djr1.1 mutants.
Interestingly, the pdr1 mutants containing a-Syn showed a trend for increased skn-1 mRNA expression, whereas the levels were decreased in the pink1 and djr1.1 mutants (Fig. 5B) . 
View Article Online
Decreased dat-1 expression in djr1.1 deletion mutants
Since previous studies supported the role of extracellular dopamine in exacerbating Mn toxicity, 39 we further investigated possible interactions between a-Syn and the dopamine transporter (DAT), the protein responsible for synaptic DA clearance. Recent evidence points to a-Syn-mediated modulation of DAT 47 as a potential mechanism for the selectivity towards DAergic neurodegeneration in PD. Using Real Time RT PCR, we show that pdr1 mutants have inherently higher dat-1 mRNA levels, whereas the expression is reduced in both Mn treated and untreated djr1.1 mutants compared to WT worms (Fig. 6 ). pink1 mutants were indistinguishable from the WT worms with respect to DA neurodegeneration and dat-1 mRNA levels (data not shown).
Discussion
The specific interactions between environmental factors and various genetic deletions associated with PD pathophysiology remain poorly understood. In the present study, the invertebrate C. elegans model was used to examine the effects of acute Mn exposure on DAergic neurotoxicity in the background of three PD-associated genes (pdr1/parkin, pink1 and djr1.1/dj1) in the absence or the presence of WT human a-Syn. The ease in genetic manipulation and breeding of nematodes allowed for the quick generation and assessment of crosses needed to evaluate DAergic neurodegeneration. Moreover, this model system allows for an alternative approach to otherwise timeconsuming and costly vertebrate models that contain intricate nervous systems, hindering more rapid investigations into neurodegenerative mechanisms.
Regarding the Mn-induced lethality in the present study, pdr1 mutants showed the highest sensitivity to acute Mn exposure. Interestingly, vulnerability of the WT worms to acute MnCl 2 exposure has changed since our previously published paper, 39 which may be due to the current use of MnCl 2 with a higher purity of >99.995%. Thus, new curves were generated. Based on the different dose-response curves of the WT worms and the deletion mutants following acute Mn exposure, we examined whether they showed a differential Mn accumulation profile compared to WT worms. Interestingly, both pdr1 and djr1.1 mutants displayed significantly enhanced intraworm Mn accumulation, as shown by ICP-MS/MS. Mn accumulation View Article Online inside the worms (and not just a measurement of metals bound to the outer worm cuticle) was also corroborated by the novel and optimized utilization of LA-ICP-MS. 48 Our laboratory has recently identified a network of Mn transporter genes responsible for controlling Mn homeostasis in worms. The smf1-3 genes are orthologues for the mammalian divalent metal transporter 1 (DMT1), with SMF-3 serving as the primary Mn uptake transporter in C. elegans. 49 Interestingly, evidence has pointed to a parkin-mediated regulation of DMT1 levels via ubiquitination in vitro. 50 As the pdr1 gene shows conservation of its ubiquitin ligase activity in nematodes, it is plausible that the loss of pdr1 enhanced Mn uptake due to the loss of transporter regulation. This interaction would be interesting to examine in this model system, as the C. elegans genome does not have nearly as many E3 ubiquitin ligases as the human genome, 51 reducing the amount of compensatory mechanisms that may be possible in vertebrate knockout models. Furthermore, previous evidence in Drosophila melanogaster has shown an increased lifespan in parkin-null flies upon exposure to metal chelators compared to controls, indicating a heightened sensitivity to endogenous copper (Cu 2+ ) and iron (Fe
2+
) levels. 52 This interaction was further supported by evidence showing a reduction of the parkin null phenotype by overexpression of a metal transcription factor (MTF-1). 53 However, previous C. elegans studies in pdr1 mutants found no increased sensitivity upon exposure to Fe 2+ and Cu 2+ . 54 Our current findings of enhanced intraworm Mn accumulation corroborate a distinctive connection between parkin and metal homeostasis that may be Mn-specific, as we have also previously found that the same pdr1 mutants do not show significantly increased methylmercury (MeHg) accumulation compared to WT animals. 55 Due to the close relationship between parkin and DJ1-associated pathways, it is possible that they may be directly regulating each other. New evidence suggests a novel role for DJ1 in reducing metal-induced cytotoxicity by directly binding metals in vitro. While this study found a weaker binding affinity for Mn compared to Cu 2+ and mercury (Hg   2+   ) , 56 the alterations in Mn homeostasis in the worms may result in subsequent intracellular dyshomeostasis of other metals that DJ1 would typically bind to. Therefore, it is feasible that the enhancement in Mn accumulation in djr1.1 mutants could be due to the lack of metal binding in these animals. Notably, both pdr1 and djr1.1 mutants showed an analogous increase in Mn accumulation, yet they possessed differential neurodegeneration profiles. Parkin has recently been shown to downregulate DJ1 protein and mRNA levels, 57 with parkin knockout mice showing increased DJ1 protein levels upon proteasomal inhibition. 58 The loss of parkin (pdr1 in our case) itself may be sufficient to cause proteasomal impairment from increased oxidative stress and abnormal accumulation of misfolded proteins. Moreover, increased expression of djr1.1 in the background of pdr1 loss might ameliorate overall neurotoxicity in these animals. While manganism is distinctive from PD in terms of the initial site of metal accumulation and toxicity (globus pallidus), View Article Online both medical conditions implicate enhanced oxidative damage. In the absence of genetic alterations, Mn itself can cause mitochondrial damage by inhibiting complex I and II of the electron transport chain (ETC) and oxidative phosphorylation. 59 Mn can also increase isoprostane (lipid peroxidation marker) generation 60 and decrease ATP levels in a dosedependent manner, resulting in increased neurodegeneration. 44 The increased intraworm Mn concentrations may also influence iron (Fe) concentrations, another heavy metal that competes with Mn for transport via DMT1 and the transferrin receptor (TfR). 61 Furthermore, iron has been implicated in PD by promoting oxidative damage via the Fenton reaction or altering oxidative response pathways. 62 Mn has also been shown to exacerbate DA oxidation to produce damaging, reactive DA intermediates. 63 The combination of Mn's own oxidative potential and enhancement of DA oxidation, represent a plausible mechanism for its selectivity towards DAergic neurodegeneration, as previously corroborated in C. elegans.
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The marked increase in baseline RONS induction in the pdr1 mutants was striking; however, this is not surprising, as parkin's significant role in mediating mitophagy warrants impaired mitochondrial integrity in its absence. 17a,64 The similarly elevated basal RONS levels in the djr1.1 mutants do not quite reach the level of the pdr1 mutants. As noted earlier, several studies have affirmed DJ1's role as an oxidative stress sensor, indicating that loss of DJ1 would inherently result in increased RONS production. 20 We posit that this inherently enhanced level of RONS induction accounts for an attenuated response upon acute Mn exposure, as these mutants exhibit a ceiling effect to the already-high baseline RONS levels. Given its role in recruiting parkin to damaged mitochondria, it was somewhat unexpected that pink1 mutants only showed a slightly enhanced RONS induction compared to WT worms. However, the presence of DJ1 in Drosophila is capable of reducing mitochondrial deficits in the background of pink1, but not parkin loss. 25 This could account for the lack of an oxidative stress phenotype in the pink1 mutants, as well as the fact that these mutants did not take up as much Mn as the pdr1 and djr1.1 mutants. While a trend was apparent towards a dose-dependent effect of Mn on GSH depletion in WT animals, the deletion mutants show no significant change with treatment. In particular, the baseline reduction in GSH levels in all deletion mutants suggests an inherently impaired ability to adapt to stressful stimuli, such as acute Mn exposure. In pdr1 mutants, this may also relate to the inherently high levels of RONS production, as they show the lowest basal total GSH levels. Moreover, it has been shown that knocking down pink1 in human neurons results in GSH reduction. 45 Similarly, DJ1 expression promotes upregulation of glutathione synthesis, 65 which corresponds with the finding in djr1.1 mutants, showing decreased GSH levels. Taken together, our data support a mechanism of neurotoxicity through compromised clearance of Mn-damaged mitochondria due to the loss of an intact parkin/PINK1/DJ1 pathway, resulting in heightened RONS production that cannot be inherently combated due to basal GSH deficiencies in the mutants.
The observed increase in RONS induction and basal GSH depletion in mutants showing enhanced Mn accumulation ( pdr1 and djr1.1) warranted further examination into whether these animals also have alterations in skn-1 expression, the worm orthologue for nrf2. Nuclear factor erythroid 2-related factor 2, or Nrf2, is a transcription factor that promotes the upregulation of antioxidant genes upon oxidative-stressinduced translocation from the cytoplasm to the nucleus. 66 Previous work has found skn-1 mutants to be vulnerable to oxidative stress. 67 While not significant, pdr1 mutants showed a trend for increased skn-1 mRNA expression, which was consistent with increased Nrf2 activity found in an induced pluripotent stem cell (iPSC) study in patients harboring parkin mutations. 68 Moreover, contrary to DJ1 acting as an Nrf2 stabilizer, 69 we found significantly increased skn-1 mRNA expression in the djr1.1 mutants. While we did not expect this increase, there may be a compensatory mechanism in these animals to counteract the basal GSH depletion that would otherwise protect against RONS production by upregulating skn-1-mediated antioxidant gene transcription. Additionally, the enhanced oxidative stress of the pdr1 and djr1.1 mutants occurs in the absence of Mn-induced DAergic neurodegeneration. Similarly, the lack of subacute Mn-induced changes in the basal ganglia has been previously shown in primates. 70 Thus, the findings in this study corroborate that
Mn is even more relevant in exacerbating genetic risk for PD. In a previously published study from our group, Mn showed a selective effect on dopaminergic neurons in WT worms 24 hours post-treatment. 39 This is not in conflict with the current study, given the use of a new, objective scoring for the degenerated architecture of CEP neurons, along with differing Mn doses newly generated from the survival curves. Although a-Syn is known to be involved in the pathogenesis of PD, its role in both neuroprotection and neurodegeneration is controversial. Mutated forms of a-Syn, (A30P, E46K, A53T) have been reported to be neurotoxic, while WT a-Syn has been implicated in neuroprotection.
71 a-Syn is a neuronal protein in vertebrates that is ubiquitously expressed at high levels in all brain regions, 72 but it is not expressed in C. elegans. Therefore, worms expressing human WT a-Syn were utilized to address the role of a-Syn in the mutated background of pdr1, pink1 and djr1.1 with respect to Mn homeostasis and oxidative stress. There is increasing evidence that a-Syn interacts with metal ions, thereby affecting their homeostasis. Initial studies of the potential to bind metals came from the ability of certain metals to catalyze a-Syn aggregation. 73 Overall, two major types of interactions between metals and a-Syn have been reported. In addition to non-specific sites of electrostatic interactions, the C-terminus contains a 119 DPDNEA motif binding site, suggesting that metal binding is driven by both electrostatic interactions and the residual structure of the a-Syn C-terminus. The C-terminal low-affinity sites have been reported to interact with different metal ions, with copper (Cu) and Fe most intensively studied. 74 Although the majority of metal ions interact with a-Syn with low affinity, the protein possesses high affinity to Cu 2+ and Fe 3+ at the N-terminal region. Modifications by redox-active metal ions may be relevant for the aggregation properties of a-Syn. 75 A co-incubation of a-Syn with Mn 2+ has been reported to induce partial folding of the protein and serve as an effective promoter of a-Syn aggregation.
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In addition to its metal binding capacity, the role of a-Syn as a cellular ferrireductase has been recently identified, providing further evidence towards the multiple roles of a-Syn in metal homeostasis. 77 One very important outcome of the present work is the novel role of a-Syn in altering Mn accumulation in the background of mutated pdr1 and djr1.1 worms, which may be partially due to an endogenous metal binding capacity. Even as a-Syn was only expressed in the DAergic neurons of the worms, the global alterations in Mn homeostasis were drastic; secretion of a-Syn into other regions cannot be excluded. 78 In fact, an environmental toxin (i.e. rotenone) has been shown to promote the release of a-Syn from enteric neurons. 79 In terms of the role of a-Syn in modulating oxidative stress responses, the loss of pdr1 or djr1.1 in a-Syn-expressing worms resulted in reduced Mn-induced RONS production, compared to worms containing the genetic deletion alone. This effect was due to the reduced Mn accumulation in the presence of a-Syn in both pdr1 and djr1.1 deletion backgrounds. Additionally, attenuated oxidative stress, in accordance with the neuroprotective role of a-Syn, has been shown in cells expressing WT a-Syn, where protection against rotenone and maneb toxicity was conferred by preservation of mitochondrial function.
71b Additionally, WT a-Syn-expressing cells also showed the ability to attenuate decreased intracellular GSH levels upon serum deprivation. 80 The results in the current study support the literature in finding a neuroprotective role of wildtype a-Syn against oxidative stress.
Since one function of a-Syn is the modulation of the dopamine transporter (DAT) and loss of dat-1 is detrimental to worm survival following acute Mn exposure, dat-1 expression was investigated. This transporter (DAT-1 in C. elegans) is involved in synaptic neurotransmitter clearance, and especially responsible for DA reuptake to remove excessive extracellular DA concentrations. 81 Inhibition of DAT leads to high extracellular DA levels. 82 In C. elegans, we have already shown that upon Mn exposure, loss of dat-1 increases Mn-induced lethality compared to WT worms, with extracellular DA exacerbating Mn-induced oxidative stress, lifespan reduction and DAergic neurodegeneration. 39 While pdr1 mutants showed inherently higher dat-1 mRNA levels, the downregulation of dat-1 mRNA in the djr1.1 mutants suggests a reduced synaptic DA clearance. This might be due to the increased DAergic neurodegeneration of the a-Syn-containing djr1.1 deletion mutants compared to the a-Syn-containing pdr1 deletion mutants. The increased dat-1 levels would suggest higher extracellular DA levels in the djr1.1 mutants as a potential mechanism behind the enhanced neurodegeneration. Taken together, these findings support the role of extracellular DA in exacerbating Mn neurotoxicity.
Conclusions
The genetically amenable C. elegans model system was utilized to examine the neuroprotective or neurotoxic role of a-Syn in mediating Mn neurotoxicity in the background of loss in the PD-associated genes pdr1, pink1 and djr1.1. For the first time, the current study provides evidence for a neuroprotective role of WT a-Syn against Mn accumulation and Mn-induced oxidative stress in the background of pdr1 and djr1.1 loss.
